(Q46694436)
Statements
A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C (English)
John G McHutchison
Mitchell L Shiffman
Ramsey C Cheung
Stuart C Gordon
Teresa L Wright
John C Pottage
Ene Ette
Scott Moseley